Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 07/29/2020 - 08:38	Opened		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Check:23517:awatkins1@usc.edu.au:22229ABD-6FA9-93C6-21A9-F2CA955585BE:Updating trust level from [2] to [4]		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Check:23515:Jeremy.law@ths.tas.gov.au:39ECD73F-1F81-EE62-C0C5-85F342F54792:Updating trust level from [2] to [4]		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Check:23505:drdebwiens@gmail.com:984C8AF9-2CB4-FAAB-EE17-73D373F383D4:Updating trust level from [2] to [4]		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Check:23481:michelle.hesse@ipn.com.au:B6CA33E5-2A56-A9FC-9141-5DBF61F1E200:Updating trust level from [2] to [4]		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Email verified	Wed, 10/12/2022 - 13:23	Email verified		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Korea		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/content/equil%C3%ADbrio-vs-burnout-durante-covid-19	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	É Amanhã! Convite Lundbeck Webinar Internacional	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Анонимен

Log Type	Authored on	Log Message	Log Node	Authored by
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 07/29/2020 - 08:38	Opened		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Check:23517:awatkins1@usc.edu.au:22229ABD-6FA9-93C6-21A9-F2CA955585BE:Updating trust level from [2] to [4]		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Check:23515:Jeremy.law@ths.tas.gov.au:39ECD73F-1F81-EE62-C0C5-85F342F54792:Updating trust level from [2] to [4]		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Check:23505:drdebwiens@gmail.com:984C8AF9-2CB4-FAAB-EE17-73D373F383D4:Updating trust level from [2] to [4]		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Check:23481:michelle.hesse@ipn.com.au:B6CA33E5-2A56-A9FC-9141-5DBF61F1E200:Updating trust level from [2] to [4]		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Email verified	Wed, 10/12/2022 - 13:23	Email verified		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Korea		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/content/equil%C3%ADbrio-vs-burnout-durante-covid-19	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 13:18	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	É Amanhã! Convite Lundbeck Webinar Internacional	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Анонимен

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER